{"version":"1.0","type":"link","title":"Phase II study of olaparib and durvalumab in patients with metastatic castration-resistant prostate cancer.","author_name":"Li C 외","author_url":"https://prs-insight.online/author/Li%20C","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/131083","thumbnail_width":1200,"thumbnail_height":630}